Big Pharma spends double on marketing and administration as it does on research, Edwards charges. A two-year delay would keep TV ads from
selling consumers on drugs that haven't been tested as safe. Plus, he would like to require drug companies to get Food and Drug Administration approval before rolling out big campaigns. His plan
includes stiffer penalties for firms that violate truth-in-advertising laws and would require them to disclose more information about a drug's side effects and effectiveness.
That would make sure "salesmanship is not trumping the facts, so people learn what the real risks are associated with these drugs," Edwards says.